Skip to main content

Leadership History

Humana: CEO History

4 leaders · 1961 to present

Who is the CEO of Humana?

James A. (Jim) Rechtin is the CEO of Humana, in the role since 2024. The first chief executive was David A. Jones Sr., from 1961.

Current CEO
James A. (Jim) Rechtin (since 2024)
First CEO
David A. Jones Sr. (1961)
Leaders documented
5
Founded
1961
NameRoleFromToYears in role
James A. (Jim) RechtinPresident and Chief Executive Officer2024Present2
Bruce BroussardFormer Chief Executive Officer2013202411
Michael B. McCallisterChairman and Chief Executive Officer2000201212
David A. Jones Sr.Co-founder, Chairman and Chief Executive Officer1961199736
Who was CEO of Humana before James A. (Jim) Rechtin?
Bruce Broussard was CEO of Humana from 2013 to 2024, before James A. (Jim) Rechtin took over in 2024.

Company Overview

Humana Inc. is a Fortune 50 health company headquartered in Louisville, Kentucky. It serves roughly 7.2 million individual and group Medicare Advantage members, millions of stand-alone Part D, Medicaid, and TRICARE beneficiaries, and patients of its CenterWell clinics, pharmacy, and home health services. Unlike diversified rivals, Humana gets nearly all of its medical membership from government-funded programs, so it is effectively a bet on Medicare Advantage and senior care.

James A. (Jim) Rechtin

President and Chief Executive Officer

2024 – Present

2 years (current)

Key Decisions & Impact

Rechtin joined Humana as President and COO in January 2024 after senior roles at Envision Healthcare and Optum, and became CEO in July 2024. He has prioritized Star Ratings recovery, margin repair in Medicare Advantage, completing the commercial exit, and expanding CenterWell primary care and pharmacy.

Legacy

Under Rechtin, Humana grew Medicare Advantage membership by more than 1 million for 2026 while planning exits covering about 600,000 members for 2027 to restore margins.

Bruce Broussard

Former Chief Executive Officer

2013 – 2024

11 years

Key Decisions & Impact

During his transformative decade as CEO, Bruce Broussard executed a fundamental strategic pivot, explicitly transforming Humana from a traditional health insurance provider into an integrated, value-based healthcare delivery organization. His most critical strategic priority was dominating the lucrative Medicare Advantage market, directing billions of dollars into specialized senior care networks and digital health platforms. He orchestrated the acquisition of Kindred at Home, definitively making Humana the largest provider of specialized home healthcare services in the United States.

Legacy

Broussard led Humana from 2013 to 2024, growing Medicare Advantage membership, creating the CenterWell brand, and completing the 2021 Kindred at Home acquisition.

Michael B. McCallister

Chairman and Chief Executive Officer

2000 – 2012

12 years

Key Decisions & Impact

McCallister became chief executive in 2000 and moved Humana into Medicare Advantage and Medicare prescription-drug plans.

Legacy

Medicare became the main source of Humana revenue under him. Bruce Broussard succeeded him at the start of 2013.

David A. Jones Sr.

Co-founder, Chairman and Chief Executive Officer

1961 – 1997

36 years

Key Decisions & Impact

Jones co-founded the company with Wendell Cherry in 1961 as a nursing-home operator and moved it into hospitals and then health insurance.

Legacy

Humana spun off its hospitals in 1993 to become a health insurer. He stepped down as chief executive in 1997 and remained chairman until 2005.

Other senior executives

These officers report to the chief executive and are not part of the CEO timeline above.

  • Celeste Mellet, Chief Financial Officer (2025 – present)Mellet was brought in to aggressively manage Humana's cost structure as the company faced a massive, unexpected spike in medical utilization rates from seniors undergoing delayed post-pandemic surgeries.Source →

Challenges & Strategic Context

Humana's main challenges in 2026 are tied to Medicare economics. First, Star Ratings: a decline in its plans' ratings for the 2026 bonus year removed a large share of quality-bonus payments, which is the main reason 2026 adjusted EPS guidance (at least $9.00) sits well below 2025's $17.14. Management is targeting a recovery in the 2027 Star Ratings that set 2028 bonus payments. Second, medical cost trend: utilization and specialty drug costs have run at high single digits, and Humana guides to an Insurance segment benefit ratio of about 92.75% for 2026. Third, policy risk: CMS rate notices, risk-adjustment model changes, and expanded RADV audits can all reduce payments. Fourth, growth versus margin: after adding more than 1 million MA members for 2026, Humana said it will exit plans covering about 600,000 members for 2027, mostly lower-rated, less profitable plans.

Humana CEO and Leadership FAQ

Who is Jim Rechtin and what is his background as CEO of Humana?

Jim Rechtin became CEO of Humana in July 2024. Rechtin is an experienced healthcare executive who previously served as CEO of Envision Healthcare, President of OptumCare (UnitedHealth Group's physician organization), and a senior leader at Bain & Company's healthcare practice.

Who was Bruce Broussard and what was his impact as CEO from 2013 to 2024?

Bruce Broussard served as Humana's CEO for over a decade, architecting Humana's transformation into a senior health leader, creating the CenterWell brand, orchestrating the $5.7 billion Kindred Healthcare acquisition, and growing Medicare Advantage membership to 6 million.

Who was Michael B. McCallister and what were his achievements as CEO from 2000 to 2012?

Michael McCallister led Humana through the historic passage of the Medicare Modernization Act of 2003 (creating Medicare Advantage and Part D) and the Affordable Care Act in 2010, positioning Humana early to capitalize on the modern Medicare revolution.

Who was David A. Jones Sr. and what was his well-known 37-year leadership legacy at Humana?

David A. Jones Sr. was Humana's co-founder, longtime CEO (1961 to 1997), and Chairman (until 2005). He executed two of the most famous corporate pivots in American business history: shifting from nursing homes to hospitals, and then from hospitals into health insurance.

What is Jim Rechtin's strategic turnaround priority for Humana?

Rechtin's immediate priorities include remediating CMS Star Ratings quality scores, executing pricing and benefit discipline to restore Medicare Advantage operating margins, expanding CenterWell clinic profitability, and streamlining corporate overhead.

Who is Dr. Sanjay Shetty and what is his executive role at Humana?

Dr. Sanjay Shetty serves as the President of CenterWell, leading the strategic expansion, clinical operations, and quality performance of CenterWell Senior Primary Care, Home Health, and Pharmacy across the United States.

How does Humana's Board of Directors maintain corporate governance and oversight?

Humana's Board of Directors is composed of independent leaders with deep expertise in medicine, health policy, finance, and technology (led by Independent Chairman Kurt J. Hilzinger), maintaining rigorous oversight of clinical quality, compliance, and capital allocation.

How did Humana handle the proposed $37 billion merger with Aetna in 2015 to 2017?

In 2015, Aetna agreed to acquire Humana for $37 billion, but the transaction was blocked by a federal court in 2017 on antitrust grounds. Humana collected a $1 billion breakup fee and successfully redeployed capital into its independent value-based care and home health roadmap.

Who is the CEO of Humana?

Jim Rechtin serves as CEO, taking over in late 2024. He succeeded Bruce Broussard, a highly respected executive who led the company for over a decade. Broussard is credited with completely abandoning the commercial employer insurance market to focus the massive company entirely on highly lucrative Medicare Advantage and in-home healthcare services.

Related Leadership Timelines

Compare executive leadership tenures and strategic transitions

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.